{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:07Z","timestamp":1786988047772,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270503"],"award-info":[{"award-number":["81270503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ejim.2014.10.007","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T20:45:44Z","timestamp":1414010744000},"page":"860-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: Using virologic response at week 4"],"prefix":"10.1016","volume":"25","author":[{"given":"Yang","family":"Xiang-hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Xiao-feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2014.10.007_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hep. Intl."},{"key":"10.1016\/j.ejim.2014.10.007_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0168-8278(90)90069-4","article-title":"Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology","volume":"10","author":"Lok","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2014.10.007_bb0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2893.2002.00385.x","article-title":"The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice","volume":"9","author":"Chan","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejim.2014.10.007_bb0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1440-1746.2004.03534.x","article-title":"Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B","volume":"20","author":"Tsubota","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2014.10.007_bb0030","first-page":"177","article-title":"Diagnostic and treatment guidelines for liver failure(2012 version)","volume":"21","author":"Liver Failure and Artificial Liver Group","year":"2013","journal-title":"Zhonghua Ganzangbing Za Zhi"},{"key":"10.1016\/j.ejim.2014.10.007_bb0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2010.06.043","article-title":"Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B","volume":"54","author":"Wong","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2014.10.007_bb0040","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3748\/wjg.v20.i16.4745","article-title":"Entecavir vs lamivudine therapy for na\u00efve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2014.10.007_bb0045","first-page":"2467","article-title":"Comparison of tenofovir and entecavir in patients with chronic HBV infection","volume":"17","author":"Ceylan","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ejim.2014.10.007_bb0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.24109","article-title":"Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"53","author":"Garg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.510310130","article-title":"Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B","volume":"31","author":"Villeneuve","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510300221","article-title":"Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy","volume":"30","author":"Liaw","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0065","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/jhep.2000.17912","article-title":"Long-term therapy of chronic hepatitis B with lamivudine","volume":"32","author":"Lau","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0075","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.21581","article-title":"Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine","volume":"45","author":"Hatakeyama","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1746.2009.06089.x","article-title":"Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure","volume":"25","author":"Sun","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2014.10.007_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/135965350601100614","article-title":"Hepatitis B, virus replication and liver disease progression: the impact of antiviral therapy","volume":"11","author":"Liaw","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ejim.2014.10.007_bb0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/135965350601100404","article-title":"Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B","volume":"11","author":"Chan","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ejim.2014.10.007_bb0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/135965350801300407","article-title":"Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B","volume":"13","author":"Wong","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ejim.2014.10.007_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.20016","article-title":"Viral features of lamivudine resistant hepatitis B genotypes A and D","volume":"39","author":"Zollner","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/jhep.2001.27563","article-title":"Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy","volume":"34","author":"Yuen","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000071460","article-title":"Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan","volume":"46","author":"Suzuki","year":"2003","journal-title":"Intervirology"},{"key":"10.1016\/j.ejim.2014.10.007_bb0115","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1086\/315519","article-title":"Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy","volume":"181","author":"Puchhammer-Stockl","year":"2000","journal-title":"J Infect Dis"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514002891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514002891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T10:03:02Z","timestamp":1650448982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620514002891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0953620514002891"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2014.10.007","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: Using virologic response at week 4","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2014.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}